Living donor liver transplantation (LDLT) remains underutilized in the United States. Barriers to LDLT and acceptance of nondirected living liver donation (ND-LLD) and liver paired exchange (LPE) are unclear. The medical and surgical directors of 99 unique transplantation programs (56 LDLT programs and 43 non-LDLT programs) were surveyed to gain insight into perceptions and practices of LDLT and types of donors utilized. The response rate was 84%. Most LDLT programs (65%) reported performing ND-LLD, though opinions regarding allocation and the need for additional evaluation of these donors were mixed. Only a minority of LDLT programs reported performing LPE (12%), but most programs (78%) would be open to cross-institutional LPE barring logistical barriers. There were significant differences between LDLT and non-LDLT programs with regard to perceived barriers to LDLT, with LDLT programs reporting mainly donor and recipient factors and non-LDLT programs reporting institutional factors (P < 0.001). Understanding perceptions and practices of LDLT, ND-LLD, and LPE is important to aid in the growth of LDLT.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9018478PMC
http://dx.doi.org/10.1002/lt.26384DOI Listing

Publication Analysis

Top Keywords

ldlt programs
16
non-ldlt programs
12
ldlt
9
programs
9
living donor
8
donor liver
8
liver transplantation
8
liver paired
8
paired exchange
8
barriers ldlt
8

Similar Publications

Early outcomes of robotic vs open living donor right hepatectomy in a US Center.

Surg Endosc

January 2025

Division of Transplant Surgery, Department of Surgery, Hume- Lee Transplant Center, Virginia Commonwealth University School of Medicine, Richmond, VA, USA.

Background: Robotic living donor hepatectomy offers potential advantages but has been limited to high-volume centers, primarily in Asia and the Middle East. We report our experience establishing a robotic living donor right hepatectomy program in a U.S.

View Article and Find Full Text PDF

Purpose Of Review: Despite technical and therapeutic advances, only 20-40% of patients with colorectal liver metastases (CRLM) have resectable disease. Historically, the remaining patients with unresectable, liver-only CRLM would receive palliative chemotherapy, with a median survival of 8 months.

Recent Findings: Liver transplantation has emerged as a viable option for selected patients with CRLM.

View Article and Find Full Text PDF

This study aimed to investigate the relationship between the IL-28B SNP rs8099917 genotype, miRNA-122 expression, and the immune mechanism of ACR after LT using anti-HCV antibody calibration. A total of 45 patients with HCV received LT. IL-28B SNP rs8099917 genotyping was used to divide patients into TT and GT groups.

View Article and Find Full Text PDF

Despite several advances in living donor liver transplant (LDLT), many potential living liver donors cannot donate their organs to their relatives because of blood group incompatibility and unsuitable anatomy. Liver paired exchange (LPE) can be used to overcome incompatibilities between living donor-recipient pairs. In this study, we report the early and late results of three and five LDLTs performed simultaneously to initiate the more complex LPE program.

View Article and Find Full Text PDF
Article Synopsis
  • The study compares anesthetic management practices between living donor liver transplantation (LDLT) in South Korea and the United States, revealing significant differences despite high response rates from anesthesiology directors in both countries.
  • Key disparities include rates of early extubation post-surgery, involvement in donor selection meetings, application of enhanced recovery protocols, and use of cell savers for donors, highlighting varying approaches to patient care.
  • Overall, the findings emphasize the need for further investigation into how these differences may affect patient outcomes in LDLT procedures across these two nations.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!